Naijacrux News:Welcome to Naijacrux Online Forum..Great Place To Get Tips Facts Updates and More ,Interact Discuss & Learn With Others !!.remember to register to enjoy much more update!!!New Updates From Naijacrux -Naijacrux Is Now Mobile Friendly - Download Our Android App On Our Forum Rules And Announcement Section.Our App Will be Live On Google Playstore And IOS Store Soon Aswell - CLICK HERE TO DOWNLOAD NAIJACRUX ANDROID APP !!! Dear Guest And Naijacrux Dedicated Members,!!! ,  You Can Now Receive Naijacrux Weekly New Post and Updates Via Email by Subscribing To Our Newsletter Using The Subscribe Button Above The Naijacrux Announcement And Discussion At The Top Home Page!!Never Miss A New Post And Updates Again.!Thank You.  !!!YOU ARE WELCOME TO NAIJACRUX INFORMATIVE LEARNING AND INTERACTIVE FORUM.This Website is an Intensive Forum of Learning We recommend you Register & Login to Enjoy much free stuffs ::>>Also remember to Update your Profile Immediately after registration. Thank you!>>>!!!!To All Advertisers And Patronizers, kindly Send Mail To [email protected] For adverts Placement. thanks!!!


Author Topic: FDA’s e-cigarette authorization: Fruity vapes not significantly better than tobacco ones  (Read 6 times)

0 Members and 1 Guest are viewing this topic.

Offline mastercode

  • Global Moderator
  • Hero Member
  • *****
  • Posts: 2983
  • Thanked: 1 times
  • Karma: +0/-0
Advertisement
FDA’s e-cigarette authorization: Fruity vapes not significantly better than tobacco ones

Disposable flavored electronic cigarette devices are displayed for sale at a store in Pinecrest, Fla., June 26, 2023. (AP Photo/Rebecca Blackwell, File)

2026-06-11T14:35:12Z


                                       

WASHINGTON (AP) —         data-gtm-enhancement-style="LinkEnhancementA" href="https://apnews.com/article/ecigarettes-fda-flavors-vaping-fruit-trump-ff2701ce00d797194666917beca43de6">Fruit-flavored e-cigarettes recently authorized by         data-gtm-enhancement-style="LinkEnhancementA" href="https://apnews.com/hub/us-food-and-drug-administration">the Food and Drug Administration were not significantly better at helping smokers quit than tobacco-flavored e-cigarettes, according to a new memo that’s likely to         data-gtm-enhancement-style="LinkEnhancementA" href="https://apnews.com/article/fda-vaping-ecigarettes-trump-makary-fe31c6e2dcda2f077134faa25e7012ad">stir new questions about the agency’s decision.

The FDA last month gave its first OK to fruit-flavored vapes — essentially endorsing them as a less-harmful alternative to traditional cigarettes. The decision came despite the agency’s longstanding position that         data-gtm-enhancement-style="LinkEnhancementA" href="https://apnews.com/article/teen-vaping-smoking-cdc-survey-d1f44bd3d8df6960215a14454f5e2e6e">such flavors appeal to children and must show extra health benefits to warrant approval for adults.

Health groups and Washington lawmakers quickly condemned the decision and have called for an explanation.

        data-gtm-enhancement-style="LinkEnhancementA" href="https://www.documentcloud.org/documents/28232264-fda-memo-on-flavored-e-cigarettes/" target="_blank" rel="noopener">A six-page FDA memo released this week provides more details about the agency’s rationale. In it, FDA regulators appear to sidestep previous statements about the risks of sweet vaping flavors while acknowledging shortcomings in the data submitted by vape manufacturer Glas Inc.


   
       
   

To meet federal standards, companies must show that their         data-gtm-enhancement-style="LinkEnhancementA" href="https://apnews.com/article/0fdefc03152c4034a1a254b6e71a7ff1">products benefit public health. In practice, that means demonstrating that their         data-gtm-enhancement-style="LinkEnhancementA" href="https://apnews.com/article/vuse-ecigarette-vaping-fda-reynolds-cigarettes-27ac73b6a56d616d842f7977538387bd">vapes help adult smokers switch or quit cigarettes, while not attracting         data-gtm-enhancement-style="LinkEnhancementA" href="https://apnews.com/article/science-health-covid-f420ece980f60d09daad9f618b5f61dc">underage use by teens.




   
       




   


Smokers who tried Glas vapes were much more likely to completely switch from cigarettes over the course of a three-month study, according to the memo.

But the data did not show “statistically significant differences” between adults using the company’s mango and blueberry flavors and those using a tobacco-flavored e-cigarette.


   
       
           
               
                   
   
   


   

 

 
 

   
   
   
 

   


       
   



               
           
       
   

That means the new vapes failed to meet the same bar as a handful of other flavored products previously sanctioned by the FDA, including menthol-flavored vapes from         data-gtm-enhancement-style="LinkEnhancementA" href="https://apnews.com/article/juul-vaping-ecigarettes-fda-teens-ban-9561d6a26972c01613c4fd3ebbbd981e">Juul and         data-gtm-enhancement-style="LinkEnhancementA" href="https://apnews.com/article/ecigarettes-menthol-fda-njoy-vaping-6493efc348291434af9d7c88601154e9">NJOY. Those companies showed that adults who used menthol were significantly more likely to cut down or quit cigarettes compared with those vaping tobacco flavors.


   
       
   

Elsewhere, FDA regulators explained that the Glas flavored vapes “did not have to demonstrate added adult benefit,” because young people were unlikely to use them. Glas requires users to unlock each e-cigarette with an age-verifying cellphone app.

The agency’s authorization also runs counter to recent FDA guidelines advising companies that fruit and dessert flavors would have to meet “a high evidentiary burden” for adult use, given their risks to children. Tobacco-flavored products are not popular with teens and generally face lower regulatory hurdles at the FDA.

The FDA document is also unusual in its brevity.

Previous FDA memos on new vaping products typically run dozens of pages. For example, last year’s document authorizing Juul’s menthol e-cigarettes was more than 90 pages and included detailed scientific data from research involving 50,000 people.

The short memo on Glas does not include key details, such as how many smokers the firm studied.

Previously, the FDA almost always posted such memos immediately after announcing an authorization. The document on Glas appeared on the agency’s website more than a month after regulators OK’d the products.


   
       
   

The agency has faced questions from members of Congress about the decision. Last month, 10 Democratic senators sent a letter to the agency requesting more information about the authorization, calling it a “shortsighted and reckless decision.”

The application from Glas, which also included menthol and tobacco-flavored vapes, followed a winding path to authorization. The small, Los Angeles-based company submitted a marketing request to the FDA in 2021, and regulators initially rejected it.

In February, FDA scientists changed course and signed off on several flavors. But that decision was blocked by a senior official reporting to         data-gtm-enhancement-style="LinkEnhancementA" href="https://apnews.com/article/fda-trump-makary-kennedy-vaccines-drugs-ef151784342c48cca3b91a829d615b5e">then-FDA Commissioner Marty Makary, according to internal memos later released by the agency.

The mango- and blueberry-flavored products were finally OK’d during Makary’s last full week leading the agency. He resigned the post after months of criticisms from industry stakeholders, including tobacco companies that have lobbied President Donald Trump’s Republican White House for looser regulations on vaping flavors.


   
       
   

A spokesperson for the company could not immediately provide comment when reached Thursday morning.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.


                                   
                               
                           

                           
                   
                   
                   

                   
                   
   
       
           
               
   
       
           
       

   

   
       
           
                MATTHEW PERRONE
           
       

       
           
                Perrone covers the intersection of medicine, business and health policy. He is based in Washington.
           
       
       
       
           
               
                   
                       
   
   
       
           
       
   
   
        twitter
   



                   
                       
   
   
       
           
       
   
   
        mailto
   



                   
               
           
           
           
                    data-social-service="LinkedIn">
   
       

   

       

       

       
     
   

   
   
       

   

   
       

   
       
    >



       

       
   

   


   

           
           
       
       
   


           
       
   


                   
                   
   



                   
   


Source: FDA’s e-cigarette authorization: Fruity vapes not significantly better than tobacco ones